KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug Pharmaceutical Investing
IMV Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA Across Five Solid Tumor Indications Biotech Investing
Nu-Med Plus Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study Medical Device Investing
IRADIMED Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan Medical Device Investing
NanoSphere Health Sciences Expands to Indiana With Evolve Formulas NanoSerum™ Hemp Cannabis Investing News
Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease Biotech Investing
Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer Pharmaceutical Investing
European Commission Approves Merck’s KEYTRUDA (pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC Pharmaceutical Investing
Masimo Announces FDA Clearance of the rainbow Acoustic Monitoring RAS-45 Sensor for Infant and Neonatal Patients Medical Device Investing
Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3 Global Registrational Trial of Bemarituzumab Biotech Investing
